Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board

Proceeds will be used to advance clinical program of GNSC-001, company's lead candidate in osteoarthritis (OA) Brian Kotzin, M.D., and Jackson Streeter, M.D., join Genascence's board of directors Company expands Scientific Advisory Board of internati... Regenerative Medicine, Orthopaedic, Venture Capital Genascence, gene therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news